Moringa Powder Acceptability Trial Among Healthy Adults
NCT ID: NCT05861076
Last Updated: 2025-01-01
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
52 participants
INTERVENTIONAL
2023-01-03
2023-05-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effects of Bronch™ on Respiratory Health
NCT04812561
Oral Nutritional Supplements in Treatment of Elderly Mild-to-Moderate COVID-19
NCT05629975
Phytochemicals on "Metabolic Aging" in Older Overweight Adults
NCT04919876
Double-Blind, Randomized, Cross-Over Trial of Aged Garlic Extract for Hypertension
NCT03211767
Effects of a Multi-Ingredient Pre-Workout Supplement on Body Composition, Performance, Muscular Properties, and Wellbeing in Adults.
NCT05769088
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The investigators are conducting a testing trial of Moringa oleifera leaves, offered as powder, to be added to foods and/or drinks to test safety, acceptability and consumption of it in three different doses: 1 tsp, 2 tsp, and 3 tsp. Study participants will be randomly allocated to one of the three doses.
Among the studies that have been conducted with human subjects (individuals with diabetes), no adverse effects have been reported with whole leaf powder at up to a single dose of 50 g or using 8 g per day dose for 40 days (Stohs \& Hartman, 2015).
The outcomes to be measured in this testing trial are the following:
* Consumption (measured by self-report and skin carotenoid level, as a biomarker of consumption of fruits and vegetables)
* Acceptability (measured by rating the taste of the moringa powder when consumed with foods/drinks)
* Safety (measured by self-report of any potential side effects, such as digestive issues due to fiber content) Results from this trial will suggest an acceptable dose in a population not yet diagnosed with a specific disease (e.g. diabetes) and therefore potentially less willing to consume it in doses that could make taste a potential barrier for consumption.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
OTHER
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Moringa Powder - Medium Dose
Group A
Moringa Powder - Medium Dose
2 teaspoons Moringa leaf powder to be consumed with usual food and/or drinks daily for 7 days
Moringa Powder - High Dose
Group B
Moringa Powder - High Dose
3 teaspoons Moringa leaf powder to be consumed with usual food and/or drinks daily for 7 days
Moringa Powder - Low Dose
Group C
Moringa Powder - Low Dose
1 teaspoon Moringa leaf powder to be consumed with usual food and/or drinks daily for 7 days
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Moringa Powder - Low Dose
1 teaspoon Moringa leaf powder to be consumed with usual food and/or drinks daily for 7 days
Moringa Powder - Medium Dose
2 teaspoons Moringa leaf powder to be consumed with usual food and/or drinks daily for 7 days
Moringa Powder - High Dose
3 teaspoons Moringa leaf powder to be consumed with usual food and/or drinks daily for 7 days
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* University of California (UC) Berkeley staff
* able to communicate in English or Spanish
Exclusion Criteria
* pregnant or lactating individuals
* individuals who already consume Moringa regularly
* individuals who have been told that they have diabetes or hypothyroidism
* individuals who are taking any medication, with the exception of over-the-counter pain medication and contraceptives
* individuals who follow a medically prescribed diet
18 Years
65 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of California, Davis
OTHER
University of California, Berkeley
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Susana Matias, PhD
Role: PRINCIPAL_INVESTIGATOR
University of California, Berkeley
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of California
Berkeley, California, United States
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Gomez-Martinez S, Diaz-Prieto LE, Vicente Castro I, Jurado C, Iturmendi N, Martin-Ridaura MC, Calle N, Duenas M, Picon MJ, Marcos A, Nova E. Moringa oleifera Leaf Supplementation as a Glycemic Control Strategy in Subjects with Prediabetes. Nutrients. 2021 Dec 24;14(1):57. doi: 10.3390/nu14010057.
Leone A, Bertoli S, Di Lello S, Bassoli A, Ravasenghi S, Borgonovo G, Forlani F, Battezzati A. Effect of Moringa oleifera Leaf Powder on Postprandial Blood Glucose Response: In Vivo Study on Saharawi People Living in Refugee Camps. Nutrients. 2018 Oct 12;10(10):1494. doi: 10.3390/nu10101494.
Stohs SJ, Hartman MJ. Review of the Safety and Efficacy of Moringa oleifera. Phytother Res. 2015 Jun;29(6):796-804. doi: 10.1002/ptr.5325. Epub 2015 Mar 24.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Statistical Analysis Plan
Related Links
Access external resources that provide additional context or updates about the study.
Stohs SJ, Hartman MJ. (2015). Review of the Safety and Efficacy of Moringa oleifera.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2022-10-15659
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.